Annals of the Rheumatic Diseases
Издатель: Elsevier · ISSN 0003-4967 · 86 статей
-
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Gonzalo Borrego-Yaniz, Vera Fuentes-Moreno, Lourdes Ortiz-Fernández, José Hernández-Rodríguez, Sarah L Mackie, Augusto Vaglio,...
-
Broad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Federica Bonaso, Bohang Jiang, Laura J Yockey, Jesse Akaa, Ian Doyle, Evan Hsu, Courtney LeSon, Grace McMahon, Isha Jha, Sydney B...
-
Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Hyo Jae Kim, Min-Gang Kim, Seongryong Kim, Mi Hyeon Kim, Seon Uk Kim, Hee Sung Kwon, Seo Yoon Ban, Hae Rim Kang, Su Young Heo, Sung...
-
Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Georgios Filippou, Laura Pezzoni, Emilio Filippucci, Sara K. Tedeschi, Tristan Pascart, Antonella Adinolfi, Edoardo Cipolletta,...
-
A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Jonathan Sormani, Antonin Chenel, Emilio Amleto Conti, Clarisse Doutriaux, Yvan Jamilloux, Thomas Henry, Jade Cognard, Thierry...
-
Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Kuniyuki Aso, Koyo Matsuzaki, Jyunnosuke Saito, Masato Tarumi, Toshio Fujimoto, Tetsuya Horita
-
Correspondence on ‘Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series’ by Siegert et al
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Yan Li, Chunyan Ma, Feng Zhang
-
Response to a Correspondence on ‘Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis – a case series’
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Elise Siegert, Elpida Phithak, Fredrik N Albach, Gerhard Krönke, Tobias Alexander, David Simon
-
Correspondence on ‘Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials’ by Annfeldt et al
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Nizhou Jiang, Yanchao Zhang, Lei Li
-
Response to correspondence on ‘Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials’ by Annfeldt et al
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Tommy K. Annfeldt, Tobias Haugegaard, Laura C. Coates, Ana-Maria Orbai, Ying-Ying Leung, Robin Christensen
-
Correspondence on ‘Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis’ by Looijen et al
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Chuanfu Zhang, Qianqian Liang
-
Response to correspondence on ‘Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis’ by Zhang et al
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Agnes E M Looijen, Paco M J Welsing, Annette H M van der Helm-van Mil, Pascal H P de Jong
-
Correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’ by Imai et al
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Preeti Lamba, Dharmendra Sharma
-
Response to correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Yuki Imai, Michihito Kono, Tomonori Ishii, Toshihisa Kojima, Shintaro Hirata, Yoshiya Tanaka, Eiichi Tanaka, Koichiro Ohmura,...
-
Corrigendum to Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: A target trial emulation study Ann Rheum Dis 2025;84(11):1938-1947
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): Masaki Hatano, Yusuke Sasabuchi, Akira Okada, Yuya Kimura, Hisatoshi Ishikura, Takeyuki Tanaka, Taku Saito, Sakae Tanaka, Hideo Yasunaga
-
Corrigendum to EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia Ann Rheum Dis. 2025 Sep;84(9):1445-1457. doi: 10.1016/j.ard.2025.01.021. Epub 2025 May 8
Publication date: November 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 11 Author(s): H.W. van Steenbergen, F. Doornkamp, S. Alivernini, J. Backlund, C. Codreanu, S.B. Cohen, B. Combe, A.P. Cope, K.D. Deane, B.R....
-
Nicotinamide N-methyltransferase drives fibroblast activation and skin fibrosis in systemic sclerosis
Publication date: Available online 2 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Anela Tosevska, Karolina von Dalwigk, Shaohua Zhu, Jiajia Pang, Lisa Gröbl, Ece Danisman, Felix Kartnig, Ana Korosec, Birgit...
-
The impact of HFE genotypes and iron loading on joint disease: evidence for HFE-associated arthropathy without genetic haemochromatosis
Publication date: Available online 2 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Patrick D.W. Kiely, Bayram Farisogullari, Stephanie Finzel, Graeme J. Carroll, Geraldine McCarthy, John Stack, Simone Parisi, Graça...
-
Global burden and economic cost of musculoskeletal disorders in the working-age population, 1990-2023
Publication date: Available online 4 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Zhanqi Wei, Xiang Ji, Ditao Lin, Zhou Chen, Zilong Wang, Hanyang Sun, Jie Tan, Chenliang Wang, Zehui Lv, Bin Feng, Fangang Meng,...
-
Blinatumomab in dermatomyositis and refractory ANCA-associated vasculitis: a 2-patient exploratory study
Publication date: Available online 5 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Ci Lu, Xuexiao Jin, Jialin Dai, Ning Shen, Shuangyue Ma, Xiayan Xu, Xin Li, Lihua Chen, Guannan Jiang, Qiao Ye, Qing Zhou, Linrong...
-
Making sense of publicly available omics dataset
Publication date: Available online 5 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Caroline Ospelt
-
Pharmaceutical blockade of the neonatal Fc receptor (FcRn) ameliorates autoimmunity, inflammation, and fibrosis in the antitopoisomerase-I antibody–driven mouse model of systemic sclerosis
Publication date: Available online 11 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Cuong Tran Manh, Christoph Liebel, Aleix Rius Rigau, Bas van der Woning, Piotr Zabrocki, Jörg H.W. Distler, Thuong Trinh-Minh
-
Validation of rheumatoid arthritis low inflammatory activity: a novel clinical target quantifying inflammatory disease activity
Publication date: Available online 13 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Joshua F. Baker, Elizabeth M.A. Hensor, Ted R. Mikuls, Katherine D. Wysham, Bryant R. England, Jennifer L. Barton, Pascale Schwab,...
-
ERN-RITA/PReS recommendations for the diagnosis, classification, monitoring, and treatment of childhood idiopathic (primary) angiitis of the central nervous system
Publication date: Available online 13 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Tamás Constantin, Kata Takács, Brian Feldman, Zoi Anastasa, Jordi Anton, Stefan Berg, Malene Landbo Børresen, Roberta Caorsi, Marco...
-
Shared and distinct inflammatory signatures in gout flare and acute CPP crystal arthritis: systemic inflammation persists in gout despite achieving serum urate target
Publication date: Available online 17 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Brenda Kischkel, Tristan Pascart, Nicholas Sumpter, Gwénaëlle Jayat, Nils Asmann, Charles Leroy, Augustin Latourte, Tim L. Jansen,...
-
AI-supported screening for systematic literature reviews informing EULAR recommendations and points to consider
Publication date: Available online 17 November 2026 Source: Annals of the Rheumatic Diseases Author(s): Lea Bischof, Jelle Jasper Teijema, Emily Westerbeek, George E. Fragoulis, Uta Kiltz, Lewin Könemann, Rens van de Schoot, Sofia...